Credit Suisse maintains its Outperform rating on Invesco IVZ and raises its price target to $26 from $25 a share on several catalysts in the company's future, as well as a cheap current valuation.
Credit Suisse says, "IVZ released stronger reported earnings and better than expected net flows: IVZ's 4Q11 adjusted EPS of $0.42 was $0.02 above our forecast and the consensus. Key areas of strength were performance fees, other revenues (PE, RE transaction fees), and a lower than expected tax rate (mgmt guided down the forward tax rate in 2012). Net long-term flows of $5.6B represent about 4% annualized organic growth (one of the highest rates in the industry), and this level exceeded our $3B
forecast."
IVZ closed at $22.78 a share on Thursday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in